Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 9/20 | 0.37 |
| ▸ | PTGER2 | P43116 | 9/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13348056 | 0.94 | FFAR1 (0.38) | PTGER4PTGER2FFAR1MAOBCD274 | |
| SCHEMBL13348160 | 0.89 | PTGER4 (0.48) | PTGER4PTGER2FFAR1MAOBHRH3 | |
| SCHEMBL13348167 | 0.86 | PTGER4 (0.40) | PTGER4PTGER2MAOBMAOA | |
| SCHEMBL13312085 | 0.86 | FFAR1 (0.48) | PTGER4PTGER2FFAR1FFAR4 | |
| SCHEMBL13348393 | 0.86 | CYP2D6 (0.37) | PTGER4PTGER2FFAR1MAOBHRH3 | |
| SCHEMBL13348388 | 0.86 | PTGER4 (0.49) | PTGER4PTGER2MAOBMAOALTA4H | |
| SCHEMBL13312651 | 0.83 | FFAR1 (0.40) | PTGER4PTGER2FFAR1CD274PDCD1 | |
| SCHEMBL13348107 | 0.83 | PTGER4 (0.44) | PTGER4PTGER2FFAR1CD274HRH3 | |
| SCHEMBL13348170 | 0.83 | PTGER4 (0.39) | PTGER4PTGER2FFAR1MAOBCD274 | |
| SCHEMBL13348114 | 0.82 | FFAR1 (0.40) | FFAR1MAOBCD274HRH3PDCD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152165-A1 | CARBOXYLIC ACID DERIVATIVES | ASTELLAS PHARMA INC. (JP) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152165-A1 | CARBOXYLIC ACID DERIVATIVES | GPR119, GPR65, HCAR1 | PTGER4 1432/4885PTGER2 3346/4885FFAR1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.